PT  - JOURNAL ARTICLE
AU  - Luo, Chongliang
AU  - Islam, Md. Nazmul
AU  - Sheils, Natalie E.
AU  - Buresh, John
AU  - Chen, Yong
TI  - dPQL: a lossless distributed algorithm for generalized linear mixed model with application to privacy-preserving hospital profiling
AID  - 10.1101/2021.05.03.21256561
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.05.03.21256561
4099  - http://medrxiv.org/content/early/2021/05/05/2021.05.03.21256561.short
4100  - http://medrxiv.org/content/early/2021/05/05/2021.05.03.21256561.full
AB  - Hospital profiling provides a quantitative comparison of health care providers for their quality of care regarding certain clinical outcomes. To implement hospital profiling, the generalized linear mixed model (GLMM) is usually used to fit clinical or administrative claims data, adjusting for the effects of covariates. For better generalizability, data across multiple hospitals, databases or networks are desired. However, due to the privacy regulation and the computation complexity of GLMM, a convenient distributed algorithm for hospital profiling is needed. In this paper, we develop a novel distributed Penalized Quasi Likelihood algorithm (dPQL) to fit GLMM, when only aggregated data, rather than the individual patient data are available across hospitals. The dPQL algorithm is based on a newly-developed distributed linear mixed model (DLMM) algorithm. This proposed dPQL algorithm is lossless, i.e. it obtains identical results as if the individual patient data are pooled from all hospitals. We demonstrate the usage of the dPQL algorithms by ranking 929 hospitals for COVID-19 mortality or referral to hospice in Asch, et al. 2020.Competing Interest StatementDrs. Sheils and Islam and Mr. Buresh are full-time employees in OptumLabs and own stock in its parent company, UnitedHealth Group, Inc.Funding StatementThis work was supported partially through a Patient-Centered Outcomes Research Institute (PCORI) Project Program Award (ME-2019C3-18315). All statements in this report, including its findings and conclusions, are solely those of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute (PCORI), its Board of Governors or Methodology Committee.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:UnitedHealth Group Certificate of Action Office of Human Research Affairs(OHRA) 160 Second Street 3rd Floor Cambridge MA, 02142 Federalwide Assurance #: FWA00028881 OHRP Registration #: IORG0010356 Investigator Name: Sheils, Natalie Action Date: 12 Nov 2020 UHG Project Number: 2020 0088 Action Type: New Initial Application Project Sponsor: No Sponsor Action ID: 2020 0088 01 Project Expiration: None Action Level: Exempt Project Risk Level: Negligible Risk Action Decision: Approved Project Title: Lossless Distributed Linear Mixed Model with Application to Integration of Heterogeneous Healthcare Data The following are included in the decision for this action: Documents: Protocol, dated 11-10-2020 CITI Training: Biomedical Research (Sheils) Regulatory Determinations: The research was determined to qualify as negligible risk and is permissible under exempt category 4 (ii). The research was determined to be exempt as the activities did not identify subjects directly or through identifiers via the claims database, subjects were not contacted, and investigators will not re-identify subjects. Notes & Reminders: Annual renewal of this project is not required. If any aspects of the project change, please engage the OHRA to determine whether any additional research determinations or risk assessments are needed. Please inform the OHRA when they project and any associated data utilization have concluded.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data are proprietary and are not available for public use but can be made available under a data use agreement to confirm the findings of the current study.